Amexdrug Valuation
| AXRX Stock | USD 0 0.00 0.00% |
Amexdrug seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Amexdrug from analyzing the firm fundamentals such as profit margin of 0.02 %, and Return On Equity of 0.29 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Amexdrug's price fluctuation is very steady at this time. Calculation of the real value of Amexdrug is based on 3 months time horizon. Increasing Amexdrug's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Amexdrug is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Amexdrug Pink Sheet. However, Amexdrug's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.002 | Real 0.00168 | Hype 0.002 | Naive 0.002 |
The intrinsic value of Amexdrug's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Amexdrug's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Amexdrug helps investors to forecast how Amexdrug pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Amexdrug more accurately as focusing exclusively on Amexdrug's fundamentals will not take into account other important factors: Amexdrug Total Value Analysis
Amexdrug is presently projected to have valuation of 34.51 M with market capitalization of 16.91 M, debt of 961.12 K, and cash on hands of 168.01 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Amexdrug fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
34.51 M | 16.91 M | 961.12 K | 168.01 K |
Amexdrug Investor Information
The company has Price/Earnings (P/E) ratio of 165.0. Amexdrug had not issued any dividends in recent years. The entity had 20:1 split on the 3rd of December 2012. Based on the key indicators obtained from Amexdrug's historical financial statements, Amexdrug is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Amexdrug Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Amexdrug has an asset utilization ratio of 450.58 percent. This suggests that the Company is making $4.51 for each dollar of assets. An increasing asset utilization means that Amexdrug is more efficient with each dollar of assets it utilizes for everyday operations.Amexdrug Profitability Analysis
The company reported the previous year's revenue of 10.43 M. Net Income was 111.36 K with profit before overhead, payroll, taxes, and interest of 1.01 M.About Amexdrug Valuation
Our relative valuation model uses a comparative analysis of Amexdrug. We calculate exposure to Amexdrug's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Amexdrug's related companies.Amexdrug Corporation, a pharmaceutical and cosmeceutical company, through its subsidiaries, primarily distributes pharmaceutical products. Amexdrug Corporation was founded in 1963 and is based in Commerce, California. AMEXDRUG CORPORATION operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on PNK Exchange. It employs 9 people.
8 Steps to conduct Amexdrug's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Amexdrug's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Amexdrug's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Amexdrug's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Amexdrug's revenue streams: Identify Amexdrug's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Amexdrug's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Amexdrug's growth potential: Evaluate Amexdrug's management, business model, and growth potential.
- Determine Amexdrug's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Amexdrug's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Amexdrug Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Quarterly Earnings Growth Y O Y | 0.369 | |
| Retained Earnings | 739.1 K |
Additional Tools for Amexdrug Pink Sheet Analysis
When running Amexdrug's price analysis, check to measure Amexdrug's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amexdrug is operating at the current time. Most of Amexdrug's value examination focuses on studying past and present price action to predict the probability of Amexdrug's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amexdrug's price. Additionally, you may evaluate how the addition of Amexdrug to your portfolios can decrease your overall portfolio volatility.